GP0301D mHSPC & nmCRPC patients study in the US

Global Patients is collaborating on a research study to better understand the experience of patients with prostate cancer who have received an androgen receptor inhibitor (ARI) as a form of treatment. The research study is being conducted with IQVIATM, a healthcare research firm (, and a pharmaceutical company that is working on developing therapies for patients with prostate cancer.We are seeking adult patients who have been diagnosed with prostate cancer, that are currently receiving treatment, but not chemotherapy.
The research will involve participating in one 60-minute telephone interview. In appreciation of your time, we are offering $150 after the interview is completed.The interview will explore your experience with fatigue in relation to your prostate cancer and associated treatments.

If you are interested in study participation, or have any questions, please contact miryam@global-patients.comMany thanks for your time and consideration! 

Join this Study
Are you already a member of Global Patients?